TRH regulates action potential shape in cerebral cortex pyramidal neurons

Brain Res. 2014 Jul 7:1571:1-11. doi: 10.1016/j.brainres.2014.05.015. Epub 2014 May 17.

Abstract

Thyrotropin releasing hormone (TRH) is a neuropeptide with a wide neural distribution and a variety of functions. It modulates neuronal electrophysiological properties, including resting membrane potential, as well as excitatory postsynaptic potential and spike frequencies. We explored, with whole-cell patch clamp, TRH effect on action potential shape in pyramidal neurons of the sensorimotor cortex. TRH reduced spike and after hyperpolarization amplitudes, and increased spike half-width. The effect varied with dose, time and cortical layer. In layer V, 0.5µM of TRH induced a small increase in spike half-width, while 1 and 5µM induced a strong but transient change in spike half-width, and amplitude; after hyperpolarization amplitude was modified at 5µM of TRH. Cortical layers III and VI neurons responded intensely to 0.5µM TRH; layer II neurons response was small. The effect of 1µM TRH on action potential shape in layer V neurons was blocked by G-protein inhibition. Inhibition of the activity of the TRH-degrading enzyme pyroglutamyl peptidase II (PPII) reproduced the effect of TRH, with enhanced spike half-width. Many cortical PPII mRNA+ cells were VGLUT1 mRNA+, and some GAD mRNA+. These data show that TRH regulates action potential shape in pyramidal cortical neurons, and are consistent with the hypothesis that PPII controls its action in this region.

Keywords: Action potential; Cortical pyramidal neuron; Cortical slices; Pyroglutamyl peptidase II; TRH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects*
  • Aminopeptidases / genetics
  • Aminopeptidases / metabolism
  • Animals
  • Animals, Newborn
  • Electric Stimulation
  • Excitatory Postsynaptic Potentials / drug effects
  • Glutamate Decarboxylase / genetics
  • Guanosine Diphosphate / analogs & derivatives
  • Guanosine Diphosphate / pharmacology
  • In Vitro Techniques
  • Male
  • Neural Pathways / drug effects
  • Neural Pathways / physiology
  • Patch-Clamp Techniques
  • Pyramidal Cells / drug effects*
  • Pyrrolidonecarboxylic Acid / analogs & derivatives
  • Pyrrolidonecarboxylic Acid / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Sensorimotor Cortex / cytology*
  • Thionucleotides / pharmacology
  • Thyrotropin-Releasing Hormone / metabolism*
  • Thyrotropin-Releasing Hormone / pharmacology*
  • Vesicular Glutamate Transport Protein 1 / metabolism

Substances

  • RNA, Messenger
  • Slc17a7 protein, rat
  • Thionucleotides
  • Vesicular Glutamate Transport Protein 1
  • Guanosine Diphosphate
  • Thyrotropin-Releasing Hormone
  • guanosine 5'-O-(2-thiodiphosphate)
  • Aminopeptidases
  • pyroglutamyl-peptidase II
  • Glutamate Decarboxylase
  • glutamate decarboxylase 2
  • Pyrrolidonecarboxylic Acid